Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.42 Trillion Total Companies: 1,736
Total Market Cap (USD)
$1.42 Trillion
Companies Listed
1,736
Largest Company
Lytix Biopharma AS
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 901 |
Lytix Biopharma AS
OL:LYTIX |
$32.92 Million | Nkr375.07 Million | Norway | Nkr10.80 | +1.89% | +2.86% | 1.59 Million |
| 902 |
POOLBEG PHARMA LS -0002
F:7JN |
$32.81 Million | €31.96 Million | Germany | €0.06 | +61.84% | +66.22% | 29.00K |
| 903 |
ONCOTHERAPY SCIENCE INC.
F:30O |
$32.63 Million | €31.79 Million | Germany | €0.10 | +0.00% | +12.22% | 1.45K |
| 904 |
Vicapsys Life Sciences Inc
PINK:VICP |
$32.59 Million | $32.59 Million | USA | $1.77 | +0.00% | +0.00% | 118.00 |
| 905 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$32.28 Million | €31.45 Million | Germany | €0.13 | +0.00% | +4.00% | 166.05K |
| 906 |
Spruce Biosciences, Inc. Common Stock
NASDAQ:SPRB |
$32.26 Million | $32.26 Million | USA | $58.75 | -8.63% | -6.43% | 1.17 Million |
| 907 |
Prescient Therapeutics Ltd
AU:PTX |
$32.21 Million | AU$52.02 Million | Australia | AU$0.06 | -3.45% | -5.08% | 29.39 Million |
| 908 |
4BASEBIO PLC EO 1
F:88Q |
$32.17 Million | €31.34 Million | Germany | €6.00 | +0.00% | -1.64% | 9.48K |
| 909 |
Q32 Bio Inc
NASDAQ:QTTB |
$32.12 Million | $32.12 Million | USA | $5.81 | -5.22% | -3.01% | 5.16 Million |
| 910 |
IMMUCELL CORP. DL-10
F:IUL |
$32.05 Million | €31.23 Million | Germany | €5.20 | -3.70% | -4.59% | 6.09K |
| 911 |
Mabion S.A.
WAR:MAB |
$31.56 Million | zł131.24 Million | Poland | zł9.13 | -2.87% | +14.70% | 1.31 Million |
| 912 |
Cellid Co. Ltd
KQ:299660 |
$31.43 Million | ₩46.02 Billion | Korea | ₩2575.00 | -4.10% | +1.38% | 11.81 Million |
| 913 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
$31.36 Million | $31.36 Million | USA | $5.80 | -8.23% | -4.61% | 4.33 Million |
| 914 |
GenMont Biotech Inc
TW:3164 |
$31.27 Million | NT$1.03 Billion | Taiwan | NT$18.50 | +1.09% | +5.41% | 1.89 Million |
| 915 |
Oncopeptides AB
ST:ONCO |
$31.24 Million | Skr350.46 Million | Sweden | Skr1.53 | -9.57% | -3.04% | 78.12 Million |
| 916 |
PDS Biotechnology Corp
NASDAQ:PDSB |
$31.00 Million | $31.00 Million | USA | $0.65 | -5.86% | -5.42% | 8.14 Million |
| 917 |
ACTINIUM PHARMAC. DL-001
F:7AY1 |
$30.98 Million | €30.18 Million | Germany | €0.98 | +4.26% | -2.30% | 5.22K |
| 918 |
Klotho Neurosciences, Inc.
NASDAQ:KLTO |
$30.81 Million | $30.81 Million | USA | $0.47 | -10.72% | +13.43% | 161.05 Million |
| 919 |
Heidelberg Pharma AG
F:HPHA |
$30.70 Million | €29.91 Million | Germany | €3.00 | +0.33% | +0.33% | 18.09K |
| 920 |
NUREXONE BIOLOGIC INC.
F:J90 |
$30.64 Million | €29.85 Million | Germany | €0.35 | -13.25% | -15.37% | 128.72K |
| 921 |
LAVA Therapeutics NV
NASDAQ:LVTX |
$30.56 Million | $30.56 Million | USA | $1.74 | +0.00% | -3.87% | 2.49 Million |
| 922 |
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH |
$30.45 Million | $30.45 Million | USA | $1.87 | -19.40% | -28.35% | 58.49 Million |
| 923 |
Nuo Therapeutics Inc
OTCQB:AURX |
$30.39 Million | $30.39 Million | USA | $1.50 | +11.11% | +11.11% | 126.81K |
| 924 |
Tetratherix Ltd
AU:TTX |
$30.35 Million | AU$49.01 Million | Australia | AU$4.77 | -14.82% | +19.25% | 339.05K |
| 925 |
Champions Oncology Inc
NASDAQ:CSBR |
$30.24 Million | $30.24 Million | USA | $5.83 | -5.97% | -1.19% | 161.45K |
| 926 |
Plus Therapeutics Inc
NASDAQ:PSTV |
$30.05 Million | $30.05 Million | USA | $0.24 | -5.60% | -21.98% | 107.27 Million |
| 927 |
ALGAE
PA:ALGAE |
$29.51 Million | €28.75 Million | France | €0.47 | +1.31% | +11.63% | 4.62 Million |
| 928 |
Mural Oncology plc
NASDAQ:MURA |
$29.47 Million | $29.47 Million | USA | $2.04 | +0.00% | +0.49% | 4.99 Million |
| 929 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$29.44 Million | $29.44 Million | USA | $1.34 | -5.63% | +7.20% | 2.16 Million |
| 930 |
PENTIXAPHARM HOLDING N AG
XETRA:PTP |
$29.25 Million | €28.49 Million | Germany | €1.87 | -1.89% | -5.84% | 841.16K |
| 931 |
MAAT PHARMA S.A. EO-1
F:4RD |
$29.19 Million | €28.44 Million | Germany | €7.00 | +0.00% | -0.28% | 42.48K |
| 932 |
Sareum Hldgs Plc
LSE:SAR |
$28.71 Million | £23.47 Million | UK | £16.00 | +3.23% | +14.29% | 5.49 Million |
| 933 |
Theranexus SA
PA:ALTHX |
$28.59 Million | €27.86 Million | France | €3.10 | +4.03% | -8.28% | 5.65 Million |
| 934 |
FERMENTALG EO -04
F:1F6 |
$28.53 Million | €27.79 Million | Germany | €0.45 | -3.12% | +11.94% | 46.60K |
| 935 |
NicOx S.A.
PA:ALCOX |
$28.49 Million | €27.75 Million | France | €0.43 | +1.18% | -4.56% | 28.82 Million |
| 936 |
Imugene Ltd
AU:IMU |
$28.49 Million | AU$46.01 Million | Australia | AU$0.18 | -2.78% | -23.91% | 23.94 Million |
| 937 |
Island Pharmaceuticals Ltd
AU:ILA |
$28.48 Million | AU$45.99 Million | Australia | AU$0.41 | +1.25% | -16.49% | 8.32 Million |
| 938 |
ACHILLES THERAP.SP.ADS/1
F:698 |
$28.46 Million | €27.73 Million | Germany | €1.33 | +0.00% | +0.00% | 42.00K |
| 939 |
ORIENTBIO Inc.
KO:002630 |
$28.37 Million | ₩41.53 Billion | Korea | ₩544.00 | +0.93% | -2.33% | 116.52 Million |
| 940 |
MINERVA NEUROSC. DL-0001
F:4MNA |
$28.05 Million | €27.32 Million | Germany | €6.75 | +1.50% | +35.00% | 2.39K |
| 941 |
Evaxion Biotech AS
NASDAQ:EVAX |
$28.02 Million | $28.02 Million | USA | $3.78 | -1.31% | +22.73% | 720.54K |
| 942 |
LTR Pharma Ltd
AU:LTP |
$27.93 Million | AU$45.10 Million | Australia | AU$0.43 | -1.16% | -7.61% | 4.35 Million |
| 943 |
Seoulin Bioscience Co.Ltd
KQ:038070 |
$27.84 Million | ₩40.77 Billion | Korea | ₩6630.00 | +0.45% | +4.91% | 1.98 Million |
| 944 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
$27.53 Million | $27.53 Million | USA | $1.64 | -1.20% | -1.20% | 21.59 Million |
| 945 |
HST Global Inc
PINK:HSTC |
$27.52 Million | $27.52 Million | USA | $0.83 | +0.00% | +0.00% | 1.75K |
| 946 |
Advagene Biopharma Co. Ltd.
TWO:6709 |
$27.45 Million | NT$908.08 Million | Taiwan | NT$30.05 | -2.91% | -2.28% | 2.15 Million |
| 947 |
Alx Oncology Holdings
NASDAQ:ALXO |
$27.41 Million | $27.41 Million | USA | $2.15 | -0.92% | +5.39% | 17.30 Million |
| 948 |
THERANEXUS EO -25
F:3VG |
$27.39 Million | €26.69 Million | Germany | €2.97 | -1.98% | -7.48% | 18.06K |
| 949 |
Instil Bio Inc.
NASDAQ:TIL |
$26.93 Million | $26.93 Million | USA | $8.34 | -2.68% | -6.61% | 1.03 Million |
| 950 |
Minerva Neurosciences Inc
NASDAQ:NERV |
$26.92 Million | $26.92 Million | USA | $7.78 | -0.89% | -2.02% | 5.03 Million |
| 951 |
Jasper Therapeutics Inc
NASDAQ:JSPR |
$26.68 Million | $26.68 Million | USA | $1.22 | -2.40% | -6.87% | 9.40 Million |
| 952 |
CEL-SCI Corp
NYSE MKT:CVM |
$26.54 Million | $26.54 Million | USA | $3.59 | -0.28% | -2.97% | 1.00 Million |
| 953 |
TWi Biotechnology, Inc.
TWO:6610 |
$26.29 Million | NT$869.79 Million | Taiwan | NT$20.10 | -0.50% | -10.07% | 10.02 Million |
| 954 |
LAVA THERAP. B.V. EO-12
F:4PKB |
$25.96 Million | €25.29 Million | Germany | €1.44 | -6.49% | +5.88% | 28.80K |
| 955 |
Galecto Inc
NASDAQ:GLTO |
$25.65 Million | $25.65 Million | USA | $21.18 | -11.79% | -26.74% | 9.84 Million |
| 956 |
INmune Bio Inc
NASDAQ:INMB |
$25.55 Million | $25.55 Million | USA | $1.24 | -3.13% | -3.13% | 11.46 Million |
| 957 |
Ascelia Pharma AB (publ)
ST:ACE |
$25.35 Million | Skr284.37 Million | Sweden | Skr3.00 | -1.96% | +3.45% | 15.19 Million |
| 958 |
Rallybio Corp
NASDAQ:RLYB |
$25.31 Million | $25.31 Million | USA | $9.36 | -3.01% | -6.40% | 6.78 Million |
| 959 |
Cynata Therapeutics Limited
PINK:CYYNF |
$25.18 Million | $25.18 Million | USA | $0.14 | +0.00% | +0.00% | 0.00 |
| 960 |
Aligos Therapeutics Inc
NASDAQ:ALGS |
$25.07 Million | $25.07 Million | USA | $6.95 | -4.79% | -2.11% | 867.34K |
| 961 |
Sharp Therapeutics Corp.
V:SHRX |
$24.89 Million | CA$35.75 Million | Canada | CA$2.25 | +0.00% | +0.00% | 50.54K |
| 962 |
ChunLab Inc
KQ:311690 |
$24.79 Million | ₩36.30 Billion | Korea | ₩8050.00 | -1.83% | -1.59% | 557.57K |
| 963 |
ProMIS Neurosciences Inc.
NASDAQ:PMN |
$24.56 Million | $24.56 Million | USA | $17.00 | -13.04% | -21.62% | 1.33 Million |
| 964 |
ABVC Biopharma Inc
NASDAQ:ABVC |
$24.26 Million | $24.26 Million | USA | $1.22 | -8.27% | -16.44% | 1.15 Million |
| 965 |
NGeneBio Co. Ltd.
KQ:354200 |
$24.17 Million | ₩35.38 Billion | Korea | ₩2040.00 | -0.97% | +5.32% | 11.63 Million |
| 966 |
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO |
$24.17 Million | $24.17 Million | USA | $1.27 | -5.93% | -2.31% | 2.03 Million |
| 967 |
Proteomics International Laboratories Ltd
AU:PIQ |
$23.93 Million | AU$38.64 Million | Australia | AU$0.31 | -3.13% | -8.82% | 7.85 Million |
| 968 |
GeneReach Biotechnology
TWO:4171 |
$23.92 Million | NT$791.51 Million | Taiwan | NT$18.90 | -0.53% | -6.67% | 4.16 Million |
| 969 |
Relief Therapeutics Holding AG
OTCQB:RLFTY |
$23.91 Million | $23.91 Million | USA | $2.49 | -17.00% | -9.45% | 1.71K |
| 970 |
Prestige BioPharma Limited
KO:950210 |
$23.88 Million | ₩34.97 Billion | Korea | ₩9740.00 | -0.10% | -2.79% | 3.48 Million |
| 971 |
India Globalization Capital Inc
NYSE MKT:IGC |
$23.70 Million | $23.70 Million | USA | $0.28 | -3.11% | -1.75% | 7.56 Million |
| 972 |
Microbix Biosystems Inc.
OTCQX:MBXBF |
$23.67 Million | $23.67 Million | USA | $0.30 | +0.00% | +4.91% | 316.20K |
| 973 |
NextCure Inc
NASDAQ:NXTC |
$23.55 Million | $23.55 Million | USA | $11.61 | -5.76% | -8.65% | 899.74K |
| 974 |
Neuraxis, Inc.
NYSE MKT:NRXS |
$23.47 Million | $23.47 Million | USA | $6.99 | -3.05% | +10.78% | 4.40 Million |
| 975 |
CervoMed Inc.
NASDAQ:CRVO |
$23.28 Million | $23.28 Million | USA | $4.24 | -6.40% | -12.76% | 2.53 Million |
| 976 |
Provectus Biopharmaceuticals Inc
OTCQB:PVCT |
$23.12 Million | $23.12 Million | USA | $0.10 | -3.00% | +5.43% | 2.98 Million |
| 977 |
Intelgenx Technologs
PINK:IGXT |
$23.05 Million | $23.05 Million | USA | $0.17 | +0.00% | +0.00% | 0.00 |
| 978 |
Barinthus Biotherapeutics plc
NASDAQ:BRNS |
$23.02 Million | $23.02 Million | USA | $0.64 | -6.03% | +13.08% | 1.22 Million |
| 979 |
D. Western Therapeutics Institute Inc
F:6DW |
$22.76 Million | €22.17 Million | Germany | €0.50 | +1.63% | +1.63% | 2.82K |
| 980 |
Level Biotechnology
TWO:3118 |
$22.63 Million | NT$748.65 Million | Taiwan | NT$33.35 | +0.91% | -1.19% | 699.82K |
| 981 |
Celularity Inc
NASDAQ:CELU |
$22.59 Million | $22.59 Million | USA | $1.25 | -0.79% | -10.07% | 8.21 Million |
| 982 |
Moleculin Biotech Inc
NASDAQ:MBRX |
$22.47 Million | $22.47 Million | USA | $2.08 | -3.70% | +5.58% | 5.95 Million |
| 983 |
Defence Therapeutics Inc
OTCQB:DTCFF |
$22.44 Million | $22.44 Million | USA | $1.00 | +0.00% | +0.00% | 0.00 |
| 984 |
Generation Bio Co
NASDAQ:GBIO |
$22.36 Million | $22.36 Million | USA | $5.34 | -6.97% | -4.81% | 2.86 Million |
| 985 |
X4 PHARMACEUTIC. DL-001
F:48Q |
$22.13 Million | €21.56 Million | Germany | €4.90 | +2900.00% | +2663.25% | 60.00K |
| 986 |
PanGen Biotech Inc
KQ:222110 |
$21.53 Million | ₩31.52 Billion | Korea | ₩4955.00 | -0.70% | +0.92% | 350.42K |
| 987 |
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU |
$21.17 Million | $21.17 Million | USA | $2.52 | -9.03% | -11.27% | 1.66 Million |
| 988 |
Atara Biotherapeutics Inc
NASDAQ:ATRA |
$21.16 Million | $21.16 Million | USA | $5.00 | -4.40% | -20.51% | 10.44 Million |
| 989 |
Telescope Innovations Corp.
PINK:TELIF |
$21.14 Million | $21.14 Million | USA | $0.29 | -1.52% | -1.52% | 31.82K |
| 990 |
Finch Therapeutics Group Inc
PINK:FNCH |
$21.11 Million | $21.11 Million | USA | $13.50 | -4.59% | -3.57% | 15.60K |
| 991 |
MARINOMED BIOTECH AG INH.
F:93Z |
$21.09 Million | €20.54 Million | Germany | €16.20 | -1.82% | +0.93% | 1.14K |
| 992 |
Molecure S.A.
WAR:MOC |
$21.04 Million | zł87.50 Million | Poland | zł6.09 | -0.33% | -13.49% | 809.30K |
| 993 |
Dyadic International Inc
NASDAQ:DYAI |
$20.99 Million | $20.99 Million | USA | $0.78 | -2.76% | -6.02% | 1.76 Million |
| 994 |
GenSight Biologics S.A
PINK:GSGTF |
$20.78 Million | $20.78 Million | USA | $0.24 | +0.00% | +0.00% | 0.00 |
| 995 |
DP8
F:DP8 |
$20.71 Million | €20.17 Million | Germany | €3.72 | +2.76% | +7.51% | 9.27K |
| 996 |
Cue Biopharma
NASDAQ:CUE |
$20.68 Million | $20.68 Million | USA | $0.26 | -2.62% | -14.71% | 46.64 Million |
| 997 |
ONCOARENDI THERAP ZY-01
F:1B1 |
$20.62 Million | €20.09 Million | Germany | €1.40 | -2.51% | -8.03% | 0.00 |
| 998 |
VistaGen Therapeutics Inc
NASDAQ:VTGN |
$20.60 Million | $20.60 Million | USA | $0.61 | -5.63% | -0.16% | 17.97 Million |
| 999 |
Amplia Therapeutics Limited
PINK:INNMF |
$20.60 Million | $20.60 Million | USA | $0.05 | -3.27% | +12.86% | 232.50K |
| 1000 |
Marinus Pharmaceuticals Inc
NASDAQ:MRNS |
$20.57 Million | $20.57 Million | USA | $0.55 | +0.00% | +0.00% | 260.00 |
| 1001 |
IMMUPHARMA PLC LS-01
F:25I |
$20.44 Million | €19.91 Million | Germany | €0.04 | -29.75% | -19.05% | 110.00K |
| 1002 |
Passage Bio Inc
NASDAQ:PASG |
$20.09 Million | $20.09 Million | USA | $7.03 | -4.61% | -17.39% | 754.81K |
| 1003 |
OnKure Therapeutics, Inc.
NASDAQ:OKUR |
$20.01 Million | $20.01 Million | USA | $4.01 | -0.25% | +13.28% | 4.08 Million |
| 1004 |
MARINUS PHARMAC. DL-001
F:61Y |
$19.96 Million | €19.44 Million | Germany | €0.52 | +0.00% | +0.00% | 6.97K |
| 1005 |
Tryptamine Therapeutics Ltd
AU:TYP |
$19.83 Million | AU$32.02 Million | Australia | AU$0.03 | +0.00% | +6.25% | 49.64 Million |
| 1006 |
Lantern Pharma Inc
NASDAQ:LTRN |
$19.67 Million | $19.67 Million | USA | $2.29 | -1.72% | -17.03% | 1.09 Million |
| 1007 |
NanoViricides Inc
NYSE MKT:NNVC |
$19.60 Million | $19.60 Million | USA | $1.12 | -0.88% | +15.24% | 6.13 Million |
| 1008 |
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD |
$19.26 Million | $19.26 Million | USA | $1.17 | +1.74% | +1.74% | 1.50 Million |
| 1009 |
Taiwan Advance Bio-Pharmaceutical Inc.
TWO:4186 |
$19.12 Million | NT$632.75 Million | Taiwan | NT$10.20 | -2.39% | -4.23% | 2.60 Million |
| 1010 |
Neuphoria Therapeutics Inc
NASDAQ:NEUP |
$19.07 Million | $19.07 Million | USA | $4.57 | -0.87% | -1.72% | 1.23 Million |
| 1011 |
EyeGene Inc
KQ:185490 |
$19.06 Million | ₩27.91 Billion | Korea | ₩1440.00 | -1.97% | +4.20% | 6.22 Million |
| 1012 |
Zelluna ASA
OL:ZLNA |
$19.01 Million | Nkr216.59 Million | Norway | Nkr19.40 | -2.99% | +19.72% | 675.06K |
| 1013 |
Vyne Therapeutics Inc
NASDAQ:VYNE |
$19.00 Million | $19.00 Million | USA | $0.58 | -4.52% | -2.84% | 7.10 Million |
| 1014 |
Allakos Inc
NASDAQ:ALLK |
$19.00 Million | $19.00 Million | USA | $0.33 | -0.06% | +0.43% | 16.83 Million |
| 1015 |
Verrica Pharmaceuticals Inc
NASDAQ:VRCA |
$18.94 Million | $18.94 Million | USA | $5.71 | -9.51% | -4.52% | 3.14 Million |
| 1016 |
Enlivex Therapeutics Ltd
NASDAQ:ENLV |
$18.84 Million | $18.84 Million | USA | $1.09 | -0.91% | -6.03% | 4.92 Million |
| 1017 |
Neurizon Therapeutics Ltd
AU:NUZ |
$18.51 Million | AU$29.90 Million | Australia | AU$0.08 | +2.50% | -2.38% | 15.23 Million |
| 1018 |
SOL-GEL TECHN. IS-10
F:4SG |
$18.46 Million | €17.98 Million | Germany | €77.50 | +0.00% | +4.03% | 724.00 |
| 1019 |
NatureWise Biotech & Medicals Corporation
TWO:4732 |
$18.46 Million | NT$610.64 Million | Taiwan | NT$19.10 | -4.98% | -4.50% | 529.11K |
| 1020 |
Marker Therapeutics Inc
NASDAQ:MRKR |
$18.33 Million | $18.33 Million | USA | $1.34 | -1.47% | -4.96% | 2.82 Million |
| 1021 |
CEL-SCI CORP. NEW DL-01
F:LSRM |
$18.29 Million | €17.82 Million | Germany | €5.87 | +2900.00% | +2643.46% | 345.90K |
| 1022 |
Dare Bioscience Inc
NASDAQ:DARE |
$18.26 Million | $18.26 Million | USA | $1.40 | -3.45% | -6.04% | 1.38 Million |
| 1023 |
NANOVIRICIDES NEW DL-01
F:NV3P |
$18.13 Million | €17.66 Million | Germany | €0.90 | +0.56% | +21.62% | 20.00K |
| 1024 |
Entropy Neurodynamics Limited
PINK:TYPTF |
$17.96 Million | $17.96 Million | USA | $0.02 | +0.00% | -25.00% | 75.53K |
| 1025 |
Radiopharm Theranostics Limited
PINK:RDPTF |
$17.87 Million | $17.87 Million | USA | $0.01 | +0.00% | +0.00% | 0.00 |
| 1026 |
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK |
$17.76 Million | $17.76 Million | USA | $0.35 | -11.55% | -21.35% | 31.10 Million |
| 1027 |
SAREUM HLDGS LS-0125
F:RYH0 |
$17.74 Million | €17.28 Million | Germany | €0.15 | +0.00% | +15.75% | 13.68K |
| 1028 |
Aptamer Sciences Inc
KQ:291650 |
$17.63 Million | ₩25.81 Billion | Korea | ₩1594.00 | +7.41% | +13.86% | 13.55 Million |
| 1029 |
Anthem Biosciences Ltd
NSE:ANTHEM |
$17.58 Million | ₹1.52 Billion | India | ₹648.40 | +1.67% | -3.25% | 6.13 Million |
| 1030 |
MEI Pharma Inc
NASDAQ:MEIP |
$17.54 Million | $17.54 Million | USA | $3.07 | +10.43% | -36.70% | 26.47 Million |
| 1031 |
Meribank Biotech Co., Ltd
TWO:4724 |
$17.48 Million | NT$578.43 Million | Taiwan | NT$14.85 | -1.00% | -10.00% | 2.83 Million |
| 1032 |
DT&CRO Co. Ltd.
KQ:383930 |
$17.45 Million | ₩25.54 Billion | Korea | ₩2885.00 | +0.00% | +0.87% | 3.36 Million |
| 1033 |
Kainos Medicine Inc
KQ:284620 |
$17.12 Million | ₩25.06 Billion | Korea | ₩1087.00 | -8.81% | +9.58% | 9.85 Million |
| 1034 |
Allarity Therapeutics Inc
NASDAQ:ALLR |
$17.08 Million | $17.08 Million | USA | $1.17 | -6.40% | -7.87% | 4.54 Million |
| 1035 |
Aadi Bioscience Inc
NASDAQ:AADI |
$17.03 Million | $17.03 Million | USA | $2.05 | +0.00% | +0.00% | 78.92K |
| 1036 |
LISATA THERAP.INC.DL-001
F:8NE |
$17.00 Million | €16.56 Million | Germany | €4.30 | +0.47% | +0.94% | 18.20K |
| 1037 |
Akari Therapeutics PLC
NASDAQ:AKTX |
$16.96 Million | $16.96 Million | USA | $0.16 | -24.72% | -36.73% | 8.11 Million |
| 1038 |
Circio Holding ASA
OL:CRNA |
$16.90 Million | Nkr192.58 Million | Norway | Nkr5.00 | -5.66% | +51.52% | 371.55 Million |
| 1039 |
PolTREG S.A.
WAR:PTG |
$16.86 Million | zł70.09 Million | Poland | zł24.80 | +0.81% | +2.90% | 78.98K |
| 1040 |
Zivo Bioscience Inc
NASDAQ:ZIVO |
$16.83 Million | $16.83 Million | USA | $8.68 | +5.04% | -8.67% | 11.92K |
| 1041 |
TaiwanJ Pharmaceuticals Co., Ltd.
TWO:6549 |
$16.79 Million | NT$555.40 Million | Taiwan | NT$7.67 | +2.40% | -1.16% | 2.06 Million |
| 1042 |
WOOJUNG BIO Inc
KQ:215380 |
$16.70 Million | ₩24.45 Billion | Korea | ₩3060.00 | -8.66% | -12.32% | 45.35 Million |
| 1043 |
Eutilex.Co.Ltd
KQ:263050 |
$16.69 Million | ₩24.44 Billion | Korea | ₩959.00 | +29.95% | +29.59% | 23.44 Million |
| 1044 |
Enimmune corporation
TWO:6564 |
$16.69 Million | NT$552.22 Million | Taiwan | NT$17.90 | +6.55% | +1.70% | 2.59 Million |
| 1045 |
Hyperion DeFi, Inc.
NASDAQ:HYPD |
$16.63 Million | $16.63 Million | USA | $3.77 | +0.27% | +14.59% | 8.39 Million |
| 1046 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT |
$16.07 Million | $16.07 Million | USA | $2.82 | -6.31% | +9.73% | 709.24K |
| 1047 |
Genolution Inc.
KQ:225220 |
$15.93 Million | ₩23.33 Billion | Korea | ₩1806.00 | +2.09% | +9.65% | 1.67 Million |
| 1048 |
Elevation Oncology Inc
NASDAQ:ELEV |
$15.88 Million | $15.88 Million | USA | $0.37 | -2.12% | -3.95% | 26.46 Million |
| 1049 |
Mink Therapeutics Inc
NASDAQ:INKT |
$15.86 Million | $15.86 Million | USA | $9.46 | -1.15% | -29.98% | 16.66 Million |
| 1050 |
Advicenne
PA:ALDVI |
$15.80 Million | €15.39 Million | France | €1.91 | -0.21% | -2.26% | 768.95K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries